| Metric | Q3'25 | Q4'25 | Change |
|---|---|---|---|
| Total Revenue | $1.95B (+5% YoY) | $2.09B (+10% YoY) | +140 bps acceleration |
| Organic Revenue | -2% YoY | +3% YoY | 500 bps inflection to positive growth |
| Adjusted EPS | $0.86 (+2% YoY) | $0.96 (+14% YoY) | +1200 bps acceleration |
| Total Orders | Up 8% YoY | Up 8% YoY | Steady momentum maintained |
| ITS Adjusted EBITDA Margin | 29.0% | 28.9% | -10 bps despite tariff headwinds |
| PST Adjusted EBITDA Margin | 30.8% | 30.4% | Still above 30%, strong execution |
| Free Cash Flow | $326M in Q3 | $462M in Q4 | +42% sequential jump |
| Recurring Revenue Run Rate | $300M+ mentioned | $450M exceeded | +50% growth with $1.1B backlog |
| M&A Investment | $460M YTD through Q3 | $525M full year | 16 deals at 9x multiple |
| China Organic Orders | Positive mentioned | Up low single digits | Third consecutive quarter positive |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.